Due to COVID-19, Capitol Hill and educational events hosted by the Alliance for Eye and Vision Research (AEVR) are currently unable to be held in person but have continued virtually. Check out our recent events below.
March 11, 2021
Glaucoma: Clinical Practice and Research to Optimize Patient Outcomes
As part of their new Research Saving Sight, Restoring Vision Initiative, the Alliance for Eye and Vision Research (AEVR) has announced their World Glaucoma Week 2021 Congressional Briefing entitled Glaucoma: Clinical Practice and Research to Optimize Patient Outcomes to be held virtually on March 11.. Featured speakers include clinician scientist-educators Mona Kaleem, MD and Elyse Joelle McGlumphy, MD—both from the Wilmer Eye Institute at the Johns Hopkins University School of Medicine—who will speak about glaucoma and their respective clinical experiences in treating patients, as well as their research efforts to better understand and optimize the patient experience. Glaucoma Research Foundation’s patient representative Amanda Eddy, who was born with glaucoma, will speak about quality-of-life challenges presented by the disease.
November 19, 2020
Thyroid Eye Disease: What Have We Learned Through Research?
Alliance for Eye and Vision Research (AEVR) continued its series of educational briefings on exciting new developments in eye and vision research by recognizing the first annual Thyroid Eye Disease Awareness Week, Nov. 16 - 20, 2020. This congressional briefing, hosted by AEVR, featured guest speakers Gary Lelli, MD, vice chair of Ophthalmology, Weill Cornell Medicine and Christine G., Thyroid Eye Disease patient advocate.
September 24, 2020
A Conversation: The Impact of COVID-19 Lab Closures on the Next Generation of Vision Scientists
View this conversation with 22 early-stage vision scientists about the impact of COVID-19 laboratory closures on their research and overall career pathway. In addition, hear from each of the Emerging Vision Scientists (EVS) in personal videos about their breakthrough eye and vision research that addresses the question, “How will this research delay, reduce, and prevent the $717 billion annual cost of eye disease and vision impairment projected by year 2050?” Watch here.
Phillip Yuhas, OD, PhD - The Ohio State University College of Optometry Ohio
Swarup Swaminathan, MD - University of Miami Bascom Palmer Eye Institute Florida
Arathy Kartha, PhD - Johns Hopkins Medicine Wilmer Eye Institute Maryland
Raven Diacou, PhD - Albert Einstein College of Medicine New York
Kevin Fuller, PhD - The University of Oklahoma Health Sciences Center Oklahoma
T.Y. Alvin Liu, MD - Johns Hopkins Medicine Wilmer Eye Institute Maryland
Eleftherios Paschalis Ilios, PhD - Massachussets Eye and Ear Massachussets
Christopher Taylor, PhD - New England College of Optometry Massachussets
Matthew Veldman, PhD - Medical College of Wisconsin Wisconsin
Lucy Mudie, MD, MPH - University of Colorado Colorado
Janet Alexander, MD - University of Maryland School of Medicine Maryland
Tareq Nabhan, OD - University of Missouri-St. Louis College of Optometry Missouri
Thomas Johnson, III, MD, PhD Johns Hopkins Medicine Wilmer Eye Institute Maryland
Benjamin Xu, PhD - University of Southern California Keck School of Medicine California
Jolene Rudell, MD, PhD - University of California San Diego California
Lauren Wareham, PhD - Vanderbilt University School of Medicine Tennessee
Nazlee Zebardast, MD - Massachussets Eye and Ear Massachussets
Speakers Becca Edwards, MD, PhD - University of Colorado Colorado
Freya Mowat, PhD - University of Wisconsin-Madison Wisconsin
Samantha McIntosh, OD - Nova Southeastern University College of Optometry Florida
Benjamin Sivyer, PhD - Oregon Health & Science University Casey Eye Institute Oregon
Xiaoying Zhu, MD, OD, PhD - SUNY College of Optometry New York
September 23, 2020
Artificial Intelligence in Retinal Diseases: Focus on Age-Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR)
As part of their Sixth Annual Emerging Vision Scientists Day on Capitol Hill recognizing International AMD Awareness Week 2020 and Health Aging Month, AEVR hosted a Congressional Briefing featuring National Eye Institute (NEI) clinician-scientist Tiarnan D. Keenan, BM, BCh, PhD and T.Y. Alvin Liu, MD, Wilmer Eye Institute/Johns Hopkins University, who discussed how Artificial Intelligence (AI) plays a key role in the diagnosis and treatment of retinal diseases. Jack Stewart, a representative from the American Macular Degeneration Foundation (AMDF), provided an AMD patient’s perspective.
July 08, 2020
How Lifestyle Changes During the COVID-19 Pandemic Can Affect Vision
With the recent reliance on digital devices for e-learning for children, remote work for adults, and communications for seniors during the COVID-19 pandemic, a panel will address potential visual implications in all stages of life, such as Digital Eye Strain and Dry Eye Disease.